From Alzheimer's Disease to Anxiety, Epilepsy to Schizophrenia: A Comprehensive Dive Into Neuro-Psychiatric Disorders

This comprehensive narrative review endeavors to dissect the intricate web of neuropsychiatric disorders that significantly impact cognition, emotion regulation, behavior, and mental health. With a keen focus on Alzheimer's disease (AD), anxiety disorders, epilepsy, schizophrenia, and autism sp...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2024-04, Vol.16 (4), p.e58776-e58776
Main Authors: Grezenko, Han, Rodoshi, Zarin Nudar, Mimms, Ciara S, Ahmed, Muhammad, Sabani, Astrit, Hlaing, May Su, Batu, Biniyam J, Hundesa, Muhidin I, Ayalew, Biruk D, Shehryar, Abdullah, Rehman, Abdur, Hassan, Ahmad
Format: Article
Language:English
Subjects:
Alzheimer's disease
Anxiety disorders
Biomarkers
Convulsions & seizures
Dementia
Disease
Dopamine
Epilepsy
Fear & phobias
Health care access
Internal Medicine
Medical Education
Medical imaging
Memory
Mental depression
Mental disorders
Neurobiology
Neuroimaging
Neurology
Neurosciences
Panic attacks
Pathology
Pathophysiology
Precision medicine
Psychosis
Schizophrenia
Stress
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This comprehensive narrative review endeavors to dissect the intricate web of neuropsychiatric disorders that significantly impact cognition, emotion regulation, behavior, and mental health. With a keen focus on Alzheimer's disease (AD), anxiety disorders, epilepsy, schizophrenia, and autism spectrum disorder (ASD), this article delves into their underlying mechanisms, clinical presentations, diagnostic challenges, and therapeutic interventions. Highlighting the considerable disability and societal costs that these conditions impose, it reflects on the over six million individuals grappling with Alzheimer's, the 19 million American adults living with anxiety disorders, the three million with epilepsy, and the global reach of schizophrenia affecting approximately 20 million people. Furthermore, it examines the emerging landscape of ASD, noting the escalating diagnosis rates and the pressing need for innovative treatments and equitable healthcare access. Through a detailed exploration of current research, technological innovations, and the promise of personalized medicine, this review aims to illuminate the complexities of these conditions, advocate for early intervention strategies, and call for a unified approach to tackling the multifaceted challenges they present. The ultimate goal is to inform and inspire healthcare professionals, researchers, and policymakers to foster advancements that improve outcomes and quality of life for individuals affected by these profound neuropsychiatric disorders, steering towards a future where these conditions are no longer insurmountable.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.58776